Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Biodesix (BDSX) over the last 5 years, with Q3 2025 value amounting to $7.5 million.

  • Biodesix's Shares Outstanding (Diluted Average) rose 252.9% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year increase of 252.9%. This contributed to the annual value of $129.7 million for FY2024, which is 5791.65% up from last year.
  • Latest data reveals that Biodesix reported Shares Outstanding (Diluted Average) of $7.5 million as of Q3 2025, which was up 252.9% from $146.7 million recorded in Q2 2025.
  • Biodesix's Shares Outstanding (Diluted Average)'s 5-year high stood at $146.7 million during Q2 2025, with a 5-year trough of $2.5 million in Q2 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $59.9 million (2022), whereas its average is $66.2 million.
  • Per our database at Business Quant, Biodesix's Shares Outstanding (Diluted Average) surged by 145703.64% in 2022 and then tumbled by 9082.29% in 2024.
  • Over the past 5 years, Biodesix's Shares Outstanding (Diluted Average) (Quarter) stood at $27.4 million in 2021, then surged by 53.86% to $42.1 million in 2022, then surged by 95.03% to $82.1 million in 2023, then surged by 57.92% to $129.7 million in 2024, then tumbled by 94.22% to $7.5 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $7.5 million for Q3 2025, versus $146.7 million for Q2 2025 and $146.5 million for Q1 2025.